Aaron B Schneir1, Jennifer Cullen, Binh T Ly. 1. Division of Medical Toxicology, University of California, San Diego Medical Center, San Diego, California 92103-8925, USA.
Abstract
BACKGROUND: "Spice" refers to various synthetic cannabinoid-containing products that seem to have rapidly become popular recreational drugs of abuse. Very little medical literature currently exists detailing the adverse effects and emergency department (ED) presentations associated with "spice" use. OBJECTIVES: To describe the presentation of 2 patients who recreationally used a "spice" product and to briefly summarize what is known about "spice" and synthetic cannabinoids. CASE REPORT: Two patients presented to the ED with, predominantly, anxiety after recreationally using a "spice" product that we subsequently confirmed to contain the synthetic cannabinoids, JWH-018 and JWH-073. CONCLUSION: We suspect that use of "spice" products may increase. Although anxiety was a prominent presentation in both of the patients described here, undoubtedly, future studies will describe the manifestations of intoxication and toxicity with the various synthetic cannabinoids.
BACKGROUND: "Spice" refers to various synthetic cannabinoid-containing products that seem to have rapidly become popular recreational drugs of abuse. Very little medical literature currently exists detailing the adverse effects and emergency department (ED) presentations associated with "spice" use. OBJECTIVES: To describe the presentation of 2 patients who recreationally used a "spice" product and to briefly summarize what is known about "spice" and synthetic cannabinoids. CASE REPORT: Two patients presented to the ED with, predominantly, anxiety after recreationally using a "spice" product that we subsequently confirmed to contain the synthetic cannabinoids, JWH-018 and JWH-073. CONCLUSION: We suspect that use of "spice" products may increase. Although anxiety was a prominent presentation in both of the patients described here, undoubtedly, future studies will describe the manifestations of intoxication and toxicity with the various synthetic cannabinoids.
Authors: Lisa K Brents; Anna Gallus-Zawada; Anna Radominska-Pandya; Tamara Vasiljevik; Thomas E Prisinzano; William E Fantegrossi; Jeffery H Moran; Paul L Prather Journal: Biochem Pharmacol Date: 2012-01-18 Impact factor: 5.858
Authors: Jason M Wiebelhaus; Justin L Poklis; Alphonse Poklis; Robert E Vann; Aron H Lichtman; Laura E Wise Journal: Drug Alcohol Depend Date: 2012-07-07 Impact factor: 4.492
Authors: S Tai; W S Hyatt; C Gu; L N Franks; T Vasiljevik; L K Brents; P L Prather; W E Fantegrossi Journal: Pharmacol Res Date: 2015-09-08 Impact factor: 7.658